tiprankstipranks
Opyl Ltd. Expands Reach with Southern CDC Agreement
Company Announcements

Opyl Ltd. Expands Reach with Southern CDC Agreement

Opyl Ltd. (AU:OPL) has released an update.

Pick the best stocks and maximize your portfolio:

Opyl Limited has entered into a Service Level Agreement with Southern Clinical Development Consulting to license its TrialKey platform, enhancing clinical trial support and optimization. This collaboration aims to improve trial design, site feasibility, and patient recruitment strategies through AI-powered insights, marking a significant expansion in Opyl’s role in clinical trial management. The agreement provides Opyl with flexible revenue opportunities, as fees are determined per project based on the scope of services.

For further insights into AU:OPL stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App